Sign Up to like & get recommendations! 0
Published in 2021 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2021.36388
Abstract: Key Points Question Can the accuracy of prognosis prediction be improved using a tumor-associated collagen signature of gastric cancer (TACSGC) to detect patients who are likely to benefit from adjuvant chemotherapy for GC? Findings In… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "JAMA oncology"
DOI: 10.1001/jamaoncol.2020.3537
Abstract: Importance The benefit of adjuvant chemotherapy after resection of pancreatic cancer following neoadjuvant combination treatment with folinic acid, fluorouracil, irinotecan, and oxaliplatin (FOLFIRINOX) is unclear. Objective To assess the association of adjuvant chemotherapy with overall… read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "JAMA oncology"
DOI: 10.1001/jamaoncol.2022.0039
Abstract: Importance Standard treatment for resectable non-small cell lung cancer (NSCLC) includes anatomic resection with adequate lymph node dissection and adjuvant chemotherapy for appropriate patients. Historically, many patients with early-stage NSCLC have not received such treatment,… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA oncology"
DOI: 10.1001/jamaoncol.2022.5808
Abstract: Importance The total number of patients with pancreatic ductal adenocarcinoma (PDAC) who receive neoadjuvant chemotherapy (NAC) is increasing. However, the added role of adjuvant chemotherapy (AC) in these patients remains unknown. Objective To evaluate the… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "JAMA surgery"
DOI: 10.1001/jamasurg.2021.2239
Abstract: Importance Women undergoing immediate breast reconstruction often require chemotherapy. The effects of chemotherapy on reconstruction are not well described. Objective To evaluate the association of neoadjuvant and adjuvant chemotherapy with complications and patient-reported outcomes (PROs)… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Cancer Medicine"
DOI: 10.1002/cam4.1553
Abstract: To identify impacts of different combined regimens of stereotactic body radiation therapy (SBRT) and chemotherapy on survival of patients with locally advanced pancreatic cancer (LAPC) and factors correlated with determinations of different combinations. Four hundred… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Cancer Medicine"
DOI: 10.1002/cam4.2491
Abstract: The American Society of Clinical Oncology guidelines recommend adjuvant chemoradiation (ACR) for margin‐positive (R1) and/or node‐positive (N+) pancreatic cancers. Our goal was to investigate if there is evidence of superiority of adjuvant chemoradiation (ACR) over… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Cancer Medicine"
DOI: 10.1002/cam4.3009
Abstract: The impact of using adjuvant chemotherapy following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with appendiceal adenocarcinoma is not known. The aim of this study was to assess the impact of adjuvant… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Cancer Medicine"
DOI: 10.1002/cam4.3363
Abstract: Adjuvant chemotherapy benefits early‐stage breast cancer (BC) patients. Older women receive guideline‐adherent treatment less frequently and experience treatment delays more frequently. We evaluated factors associated with delaying adjuvant chemotherapy and the delays’ survival impact in… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.4570
Abstract: Although cytotoxic platinum‐based adjuvant chemotherapy (pACT) has been recommended for patients with completely resected early‐stage (ES) non–small‐cell lung cancer (ES‐NSCLC), therapeutic regimens for NSCLC have evolved in the past two decades. The study was aimed… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.4698
Abstract: The pre‐adjuvant chemotherapy (PAC) status of postoperative pancreatic ductal adenocarcinoma (PDAC) patients has not been studied and elaborated well previously. read more here.